Fredun Pharmaceuticals Limited (BOM:539730)

Fredun Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	-	10.72	29.47	19.38	9.95	27.48
Short-Term Investments	-	2.41	1.51	1.08	1.09	2.93
Trading Asset Securities	-	8.08	3.08	0.58	0.58	0.49
Cash & Short-Term Investments	17.3	21.21	34.05	21.04	11.62	30.89
Cash Growth	-	-37.73%	61.84%	81.16%	-62.41%	116.11%
Accounts Receivable	-	648.49	345.6	902.73	410.75	389.74
Other Receivables	-	-	-	0.16	0.18	0.17
Receivables	-	650.95	347.11	903.79	418.19	391.45
Inventory	-	1,750	1,501	464.6	675.75	504.62
Restricted Cash	-	0.38	3.38	0.26	0.25	0.19
Other Current Assets	-	149.49	276.34	136.81	195.01	166.09
Total Current Assets	-	2,572	2,162	1,526	1,301	1,093
Property, Plant & Equipment	-	461.53	386.26	322.82	303.25	309.27
Long-Term Investments	-	4.66	0.03	0.03	0.03	0.03
Other Intangible Assets	-	4.2	3.08	0.56	0.27	0.41
Other Long-Term Assets	-	33.61	21.32	19.98	11.83	10.84
Total Assets	-	3,076	2,573	1,870	1,616	1,414
Accounts Payable	-	629.47	593.43	486.17	599.61	462.23
Accrued Expenses	-	27.98	27.47	24.45	20.53	17.42
Short-Term Debt	-	867.6	677.09	186.19	167.37	283.31
Current Portion of Long-Term Debt	-	59.52	33.98	-	-	-
Current Income Taxes Payable	-	55.35	42.9	27.91	11.26	25.69
Other Current Liabilities	-	28.36	21.7	12.79	65.8	71.24
Total Current Liabilities	-	1,668	1,397	737.5	864.56	859.89
Long-Term Debt	-	127.98	154.4	420.39	291.11	114.96
Long-Term Deferred Tax Liabilities	-	41.37	38.43	14.31	13.77	9.41
Other Long-Term Liabilities	-	12.04	9.67	7.05	6.04	6.39
Total Liabilities	-	1,861	1,609	1,189	1,185	1,001
Common Stock	-	46.99	45.32	44.33	39.9	39.9
Additional Paid-In Capital	-	714.27	549.69	454.12	271.55	271.55
Retained Earnings	-	437.73	285.48	180.04	119.26	101.77
Comprehensive Income & Other	-	15.72	83.27	2.13	-	-
Total Common Equity	1,309	1,215	963.76	680.61	430.7	413.21
Shareholders' Equity	1,309	1,215	963.76	680.61	430.7	413.21
Total Liabilities & Equity	-	3,076	2,573	1,870	1,616	1,414
Total Debt	1,372	1,055	865.47	606.59	458.48	398.27
Net Cash (Debt)	-1,354	-1,034	-831.41	-585.54	-446.87	-367.37
Net Cash Per Share	-290.71	-222.73	-185.67	-141.03	-112.00	-92.08
Filing Date Shares Outstanding	4.72	4.7	4.53	4.43	3.99	3.99
Total Common Shares Outstanding	4.72	4.7	4.53	4.43	3.99	3.99
Working Capital	-	903.72	765.54	788.99	436.25	233.34
Book Value Per Share	277.16	258.50	212.64	153.54	107.96	103.57
Tangible Book Value	1,305	1,211	960.68	680.05	430.43	412.8
Tangible Book Value Per Share	276.28	257.60	211.96	153.42	107.89	103.47
Land	-	5.24	5.24	5.24	5.24	5.24
Buildings	-	220.93	210.02	210.02	200.76	200.76
Machinery	-	391.07	289.59	198.63	167.08	153.28

Source: S&P Global Market Intelligence. Standard template. Financial Sources.